경직 치료 시장(2026-2030년)

The global spasticity treatment market is forecasted to grow by USD 1395.5 mn during 2025-2030, accelerating at a CAGR of 4.5% during the forecast period. The report on the global spasticity treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of associated neurological conditions, technological advancements in treatment solutions, growing awareness and enhanced diagnostic frameworks.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global spasticity treatment market is segmented as below:

By Type

• Drug therapy
• Physical therapy
• Surgical treatment

By End-User

• Hospitals
• Ambulatory surgical centers
• Home care settings
• Specialty clinics
• Diagnostic centers

By Indication

• Cerebral palsy
• Multiple sclerosis
• Traumatic brain injury
• Others

By Route Of Administration

• Oral
• Parenteral

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the shift towards personalized and patient-centric treatment paradigms as one of the prime reasons driving the global spasticity treatment market growth during the next few years. Also, increasing adoption of non-invasive neuromodulation techniques and integration of digital health and telemedicine in spasticity care will lead to sizable demand in the market.

The report on the global spasticity treatment market covers the following areas:

• Global spasticity treatment market sizing
• Global spasticity treatment market forecast
• Global spasticity treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global spasticity treatment market vendors that include AbbVie Inc., Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., BioWave Ltd., Boston Scientific Corp., BrainsWay Ltd., Flowonix Medical Inc., Ipsen Pharma, Jazz Pharmaceuticals Plc, LivaNova PLC, Medtronic Plc, Merz Pharma GmbH KGaA, NEURONETICS Inc., Novartis AG, Revance Therapeutics Inc., Saebo Inc, Saluda Medical Pty Ltd., Saol Therapeutics, Teva Pharmaceutical Ltd., Theranica Bio Electronics Ltd.. Also, the global spasticity treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Indication
  • Executive Summary - Chart on Market Segmentation by Route of Administration
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Spasticity Treatment Market 2020 - 2024
  • Historic Market Size - Data Table on Global Spasticity Treatment Market 2020 - 2024 ($ million)
• 5.2 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Indication segment analysis 2020 - 2024
  • Historic Market Size - Indication Segment 2020 - 2024 ($ million)
• 5.5 Route of Administration segment analysis 2020 - 2024
  • Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
• 5.6 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.7 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global spasticity treatment market
• 6.2 Impact of geopolitical conflicts on global spasticity treatment market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Type

• 8.1 Market segments
• 8.2 Comparison by Type
• 8.3 Drug therapy - Market size and forecast 2025-2030
• 8.4 Physical therapy - Market size and forecast 2025-2030
• 8.5 Surgical treatment - Market size and forecast 2025-2030
• 8.6 Market opportunity by Type
  • Market opportunity by Type ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals - Market size and forecast 2025-2030
• 9.4 Ambulatory surgical centers - Market size and forecast 2025-2030
• 9.5 Home care settings - Market size and forecast 2025-2030
• 9.6 Specialty clinics - Market size and forecast 2025-2030
• 9.7 Diagnostic centers - Market size and forecast 2025-2030
• 9.8 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Indication

• 10.1 Market segments
• 10.2 Comparison by Indication
• 10.3 Cerebral palsy - Market size and forecast 2025-2030
• 10.4 Multiple sclerosis - Market size and forecast 2025-2030
• 10.5 Traumatic brain injury - Market size and forecast 2025-2030
• 10.6 Others - Market size and forecast 2025-2030
• 10.7 Market opportunity by Indication
  • Market opportunity by Indication ($ million)

11 Market Segmentation by Route of Administration

• 11.1 Market segments
• 11.2 Comparison by Route of Administration
• 11.3 Oral - Market size and forecast 2025-2030
• 11.4 Parenteral - Market size and forecast 2025-2030
• 11.5 Market opportunity by Route of Administration
  • Market opportunity by Route of Administration ($ million)

12 Customer Landscape

• 12.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

• 13.1 Geographic segmentation
• 13.2 Geographic comparison
• 13.3 North America - Market size and forecast 2025-2030
  • 13.3.1 US - Market size and forecast 2025-2030
  • 13.3.2 Canada - Market size and forecast 2025-2030
  • 13.3.3 Mexico - Market size and forecast 2025-2030
• 13.4 Europe - Market size and forecast 2025-2030
  • 13.4.1 Germany - Market size and forecast 2025-2030
  • 13.4.2 UK - Market size and forecast 2025-2030
  • 13.4.3 France - Market size and forecast 2025-2030
  • 13.4.4 Italy - Market size and forecast 2025-2030
  • 13.4.5 Spain - Market size and forecast 2025-2030
  • 13.4.6 The Netherlands - Market size and forecast 2025-2030
• 13.5 Asia - Market size and forecast 2025-2030
  • 13.5.1 China - Market size and forecast 2025-2030
  • 13.5.2 Japan - Market size and forecast 2025-2030
  • 13.5.3 India - Market size and forecast 2025-2030
  • 13.5.4 South Korea - Market size and forecast 2025-2030
  • 13.5.5 Indonesia - Market size and forecast 2025-2030
  • 13.5.6 Thailand - Market size and forecast 2025-2030
• 13.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 13.6.1 Brazil - Market size and forecast 2025-2030
  • 13.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 13.6.3 UAE - Market size and forecast 2025-2030
  • 13.6.4 Turkey - Market size and forecast 2025-2030
  • 13.6.5 Argentina - Market size and forecast 2025-2030
  • 13.6.6 Colombia - Market size and forecast 2025-2030
  • 13.6.7 South Africa - Market size and forecast 2025-2030
  • 13.6.8 Israel - Market size and forecast 2025-2030
• 13.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

14 Drivers, Challenges, and Opportunity

• 14.1 Market drivers
  • Increasing prevalence of associated neurological conditions
  • Technological advancements in treatment solutions
  • Growing awareness and enhanced diagnostic frameworks
• 14.2 Market challenges
  • High cost of advanced therapies and stringent reimbursement policies
  • Limited access to multidisciplinary specialized care and diagnostic challenges
  • Adverse side effects and adherence issues associated with current treatments
• 14.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 14.4 Market opportunities
  • Shift towards personalized and patient-centric treatment paradigms
  • Increasing adoption of non-invasive neuromodulation techniques
  • Integration of digital health and telemedicine in spasticity care

15 Competitive Landscape

• 15.1 Overview
• 15.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 15.3 Landscape disruption
  • Overview on factors of disruption
• 15.4 Industry risks
  • Impact of key risks on business

16 Competitive Analysis

• 16.1 Companies profiled
  • Companies covered
• 16.2 Company ranking index
  • Company ranking index
• 16.3 Market positioning of companies
  • Matrix on companies position and classification
• 16.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Business segments
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
  • AbbVie Inc. - Segment focus
  • SWOT
• 16.5 Amneal Pharmaceuticals Inc.
  • Amneal Pharmaceuticals Inc. - Overview
  • Amneal Pharmaceuticals Inc. - Business segments
  • Amneal Pharmaceuticals Inc. - Key news
  • Amneal Pharmaceuticals Inc. - Key offerings
  • Amneal Pharmaceuticals Inc. - Segment focus
  • SWOT
• 16.6 Bausch Health Companies Inc.
  • Bausch Health Companies Inc. - Overview
  • Bausch Health Companies Inc. - Business segments
  • Bausch Health Companies Inc. - Key offerings
  • Bausch Health Companies Inc. - Segment focus
  • SWOT
• 16.7 Boston Scientific Corp.
  • Boston Scientific Corp. - Overview
  • Boston Scientific Corp. - Business segments
  • Boston Scientific Corp. - Key news
  • Boston Scientific Corp. - Key offerings
  • Boston Scientific Corp. - Segment focus
  • SWOT
• 16.8 BrainsWay Ltd.
  • BrainsWay Ltd. - Overview
  • BrainsWay Ltd. - Product / Service
  • BrainsWay Ltd. - Key offerings
  • SWOT
• 16.9 Ipsen Pharma
  • Ipsen Pharma - Overview
  • Ipsen Pharma - Business segments
  • Ipsen Pharma - Key offerings
  • Ipsen Pharma - Segment focus
  • SWOT
• 16.10 Jazz Pharmaceuticals Plc
  • Jazz Pharmaceuticals Plc - Overview
  • Jazz Pharmaceuticals Plc - Product / Service
  • Jazz Pharmaceuticals Plc - Key news
  • Jazz Pharmaceuticals Plc - Key offerings
  • SWOT
• 16.11 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key news
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
  • SWOT
• 16.12 Merz Pharma GmbH KGaA
  • Merz Pharma GmbH KGaA - Overview
  • Merz Pharma GmbH KGaA - Product / Service
  • Merz Pharma GmbH KGaA - Key offerings
  • SWOT
• 16.13 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
  • SWOT
• 16.14 Saebo Inc
  • Saebo Inc - Overview
  • Saebo Inc - Product / Service
  • Saebo Inc - Key offerings
  • SWOT
• 16.15 Saluda Medical Pty Ltd.
  • Saluda Medical Pty Ltd. - Overview
  • Saluda Medical Pty Ltd. - Product / Service
  • Saluda Medical Pty Ltd. - Key offerings
  • SWOT
• 16.16 Saol Therapeutics
  • Saol Therapeutics - Overview
  • Saol Therapeutics - Product / Service
  • Saol Therapeutics - Key offerings
  • SWOT
• 16.17 Teva Pharmaceutical Ltd.
  • Teva Pharmaceutical Ltd. - Overview
  • Teva Pharmaceutical Ltd. - Business segments
  • Teva Pharmaceutical Ltd. - Key news
  • Teva Pharmaceutical Ltd. - Key offerings
  • Teva Pharmaceutical Ltd. - Segment focus
  • SWOT
• 16.18 Theranica Bio Electronics Ltd.
  • Theranica Bio Electronics Ltd. - Overview
  • Theranica Bio Electronics Ltd. - Product / Service
  • Theranica Bio Electronics Ltd. - Key offerings
  • SWOT

17 Appendix

• 17.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 17.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 17.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 17.4 Research methodology
  • Research methodology
• 17.5 Data procurement
  • Information sources
• 17.6 Data validation
  • Data validation
• 17.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 17.8 Data synthesis
  • Data synthesis
• 17.9 360 degree market analysis
  • 360 degree market analysis
• 17.10 List of abbreviations
  • List of abbreviations